<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - TADALAFIL</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>TADALAFIL</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#nationalFunding" data-toggle="tab">National funding/access decisions</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pulmonary arterial hypertension</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                40 mg once daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Erectile dysfunction</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 10 mg once daily (max. per dose 20 mg), to be taken at least 30 minutes before sexual activity, subsequent doses adjusted according to response, the effect of intermittent dosing may persist for longer than 24 hours, daily dose of 10&#8211;20mg not recommended; maximum 1 dose per day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Erectile dysfunction; for patients who anticipate sexual activity at least twice a week</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5 mg once daily, reduced to 2.5 mg once daily, adjusted according to response, the effect of intermittent dosing may persist for longer than 24 hours.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Benign prostatic hyperplasia</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5 mg once daily.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Manufacturer advises avoid.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="doseAdjustments">
              <p>For pulmonary arterial hypertension use initial dose of 20&#8239;mg once daily in mild to moderate impairment.</p><p>Use maximum dose of 10&#8239;mg in erectile dysfunction and benign prostatic hyperplasia.</p>
            </section>
            <section class="generalInformation">
              <p>When used for pulmonary arterial hypertension, avoid in severe impairment.</p><p>Manufacturer advises caution in severe impairment and for regular once-daily dosing in erectile dysfunction and benign prostatic hyperplasia&#8212;no information available.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <p>In pulmonary arterial hypertension for patients with mild to moderate impairment, initially use 20&#8239;mg once daily, increased to 40&#8239;mg once daily if tolerated.</p><p>For erectile dysfunction and benign prostatic hyperplasia, maximum dose 10&#8239;mg if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> (avoid regular once-daily dosing).</p>
            </section>
        
            <section class="generalInformation">
              <p>In pulmonary arterial hypertension, avoid in severe impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>History of non-arteritic anterior ischaemic optic neuropathy</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Back pain, dyspepsia, flushing, headache, myalgia, nausea, vomiting,
              </p>
              <p>
                <strong>uncommon:</strong> Hypertension, tachycardia,
              </p>
              <p>
                <strong>notKnown:</strong> Arrhythmia, myocardial infarction, non-arteritic anterior ischaemic optic neuropathy (stop drug if sudden visual impairment occurs), retinal vascular occlusion, sudden hearing loss (discontinue drug and seek medical advice), unstable angina,
              </p>
        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> dizziness, migraine, nasal congestion, visual disturbances, dizziness, migraine, nasal congestion, visual disturbances, blurred vision, chest pain, epistaxis, facial oedema, gastro-oesophageal reflux, hypotension, increased uterine bleeding, limb pain, nasopharyngitis, palpitation, rash,
              </p>
              <p>
                <strong>uncommon:</strong> epistaxis, hypotension, painful red eyes, palpitation, epistaxis, hypotension, painful red eyes, palpitation, amnesia, hyperhidrosis, priapism, seizures,
              </p>
              <p>
                <strong>rare:</strong> facial oedema, hypersensitivity reactions, priapism, rash, Stevens-Johnson syndrome, syncope, facial oedema, hypersensitivity reactions, priapism, rash, Stevens-Johnson syndrome, syncope,
              </p>
              <p>
                <strong>notKnown:</strong> abdominal pain, increased sweating, seizures, serious cardiovascular events, transient amnesia, abdominal pain, increased sweating, seizures, serious cardiovascular events, transient amnesia, Stevens-Johnson syndrome, stroke, visual field defect,
              </p>
        
        
      </section>



      <section class="tab-pane" id="nationalFunding">
        <h2>National funding/access decisions</h2>

      </section>


      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used for benign prostatic hyperplasia:</strong>
            anatomical deformation of the penis (e.g. angulation, cavernosal fibrosis, Peyronie&#8217;s disease)
          </li>
          <li>
              <strong>When used for benign prostatic hyperplasia:</strong>
            cardiovascular disease
          </li>
          <li>
              <strong>When used for benign prostatic hyperplasia:</strong>
            left ventricular outflow obstruction
          </li>
          <li>
              <strong>When used for benign prostatic hyperplasia:</strong>
            predisposition to priapism (e.g. in sickle-cell disease, multiple myeloma, or leukaemia)
          </li>
          <li>
              <strong>When used for erectile dysfunction:</strong>
            anatomical deformation of the penis (e.g. angulation, cavernosal fibrosis, Peyronie&#8217;s disease)
          </li>
          <li>
              <strong>When used for erectile dysfunction:</strong>
            cardiovascular disease
          </li>
          <li>
              <strong>When used for erectile dysfunction:</strong>
            left ventricular outflow obstruction
          </li>
          <li>
              <strong>When used for erectile dysfunction:</strong>
            predisposition to priapism (e.g. in sickle-cell disease, multiple myeloma, or leukaemia)
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            anatomical deformation of the penis
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            aortic and mitral valve disease
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            congestive cardiomyopathy
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            coronary artery disease
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            hereditary degenerative retinal disorders
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            hypotension (avoid if systolic blood pressure below 90&#8239;mmHg)
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            left ventricular dysfunction
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            life-threatening arrhythmias
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            pericardial constriction
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            predisposition to priapism
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            pulmonary veno-occlusive disease
          </li>
          <li>
              <strong>When used for pulmonary arterial hypertension:</strong>
            uncontrolled hypertension
          </li>
        </ul>
      </section>













      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of TADALAFIL</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        

            <div id="PHP75706"><a href="../medicinalForm/PHP75706.html" data-target="#PHP75706" data-action="load">Tablet</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
